Abstract
Purpose
The prognostic significance of the mean corpuscular volume (MCV) and red cell distribution width (RDW) in patients with malignancy have not been intensely investigated and are largely overlooked. We, therefore, investigated the clinical significance of MCV and RDW in non-metastatic obstructive colorectal cancer (OCRC) patients with a self-expandable metallic stent inserted as a bridge to curative surgery.
Methods
Eighty-five pathological stage II and III OCRC patients were retrospectively evaluated. The associations of the preoperative MCV and RDW values with short- and long-term outcomes were examined.
Results
There were 50 males and 35 females, and the median age was 71 years old. The median interval between stenting and surgery was 17 days, and the median postoperative hospital stay was 16 days. Fifty-six patients were in the MCV ≥ 87 group, and 47 were in the RDW ≥ 13.8 group. Multivariate analyses revealed the MCV ≥ 87 status to be independently associated with a poor relapse-free survival (hazard ratio [HR] = 4.70, 95% confidence interval [CI] 1.52–14.58, P = 0.007). The RDW ≥ 13.8% was an independent predictor of postoperative infectious complications (HR = 7.28, 95% CI 1.24–42.70, P = 0.028).
Conclusion
The MCV and RDW are simple but strong predictors of postoperative outcomes in OCRC patients.
Similar content being viewed by others
Change history
03 June 2022
A Correction to this paper has been published: https://doi.org/10.1007/s00595-022-02527-2
References
The Global Cancer Observatory. 2020. https://gco.iarc.fr/ Accessed 6 Dec 2021.
McCullough JA, Engledow AH. Treatment options in obstructed left-sided colonic cancer. Clin Oncol (R Coll Radiol). 2010;22:764–70.
Matsuda A, Miyashita M, Matsumoto S, Matsutani T, Sakurazawa N, Takahashi G, et al. Comparison of long-term outcomes of colonic stent as “bridge to surgery” and emergency surgery for malignant large-bowel obstruction: a meta-analysis. Ann Surg Oncol. 2015;22:497–504.
van Hooft JE, Veld JV, Arnold D, Beets-Tan RGH, Everett S, Götz M, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline—Update 2020. Endoscopy. 2020;52:389–407.
Dohomoto M. New method-endoscopic implantation of rectal stent in palliative treatment of malignant stenosis. Endosc Dig. 1991;3:1507–12.
Amelung FJ, Burghgraef TA, Tanis PJ, van Hooft JE, Ter Borg F, Siersema PD, et al. Critical appraisal of oncological safety of stent as bridge to surgery in left-sided obstructing colon cancer; a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2018;131:66–75.
Ribeiro IB, Bernardo WM, Martins BDC, de Moura DTH, Baba ER, Josino IR, et al. Colonic stent versus emergency surgery as treatment of malignant colonic obstruction in the palliative setting: a systematic review and meta-analysis. Endosc Int Open. 2018;6:E558–67.
Kuwai T, Tamaru Y, Kusunoki R, Yoshida S, Matsuzawa T, Isayama H, et al. Long-term outcomes of standardized colonic stenting using WallFlex as a bridge to surgery: multicenter prospective cohort study. Dig Endosc. 2021. https://doi.org/10.1111/den.14137.
Nagai H, Yuasa N, Takeuchi E, Miyake H, Yoshioka Y, Miyata K. The mean corpuscular volume as a prognostic factor for colorectal cancer. Surg Today. 2018;48:186–94.
Mizuno H, Yuasa N, Takeuchi E, Miyake H, Nagai H, Yoshioka Y, et al. Blood cell markers that can predict the long-term outcomes of patients with colorectal cancer. PLoS ONE. 2019;14:e0220579.
Kust D, Lucijanic M, Urch K, Samija I, Celap I, Kruljac I, et al. Clinical and prognostic significance of anisocytosis measured as a red cell distribution width in patients with colorectal cancer. QJM. 2017;110:361–7.
Matsuzawa T, Ishida H, Yoshida S, Isayama H, Kuwai T, Maetani I, et al. A Japanese Prospective Multicenter Study of self-expandable metal stent placement for malignant colorectal obstruction: short-term safety and efficacy within 7 days of stent procedure in 513 cases. Gastrointest Endosc. 2015;82:697–707.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, et al. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl. 2013;48:452–8.
Yoshida N, Kosumi K, Tokunaga R, Baba Y, Nagai Y, Miyamoto Y, et al. Clinical importance of mean corpuscular volume as a prognostic marker after esophagectomy for esophageal cancer: a retrospective study. Ann Surg. 2020;271:494–501.
Zheng YZ, Dai SQ, Li W, Cao X, Li Y, Zhang LJ, et al. Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma. World J Gastroenterol. 2013;19:2811–7.
Jomrich G, Hollenstein M, John M, Ristl R, Paireder M, Kristo I, et al. High mean corpuscular volume predicts poor outcome for patients with gastroesophageal adenocarcinoma. Ann Surg Oncol. 2019;26:976–85.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology, Colon Cancer, Version 3. 2021. https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf Accessed 15 Jan 2022
Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20:207–39.
Sakamoto K, Ogawa K, Inoue H, Shine M, Matsui T, Nishi Y, et al. Significant association between the preoperative erythrocyte mean corpuscular volume and infectious complications after pancreaticoduodenectomy. Surg Today. 2021;51:258–67.
Myojo M, Iwata H, Kohro T, Sato H, Kiyosue A, Ando J, et al. Prognostic implication of macrocytosis on adverse outcomes after coronary intervention. Atherosclerosis. 2012;221:148–53.
Tennankore KK, Soroka SD, West KA, Kiberd BA. Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study. BMC Nephrol. 2011;12:19.
Yoon HJ, Kim K, Nam YS, Yun JM, Park M. Mean corpuscular volume levels and all-cause and liver cancer mortality. Clin Chem Lab Med. 2016;54:1247–57.
Lam AP, Gundabolu K, Sridharan A, Jain R, Msaouel P, Chrysofakis G, et al. Multiplicative interaction between mean corpuscular volume and red cell distribution width in predicting mortality of elderly patients with and without anemia. Am J Hematol. 2013;88:E245–9.
Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79:203–8.
Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 2006;4:236–41.
Savage DG, Ogundipe A, Allen RH, Stabler SP, Lindenbaum J. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci. 2000;319:343–52.
Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, et al. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease. Nephrology (Carlton). 2013;18:728–35.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49:1603–16.
Mohanty JG, Nagababu E, Rifkind JM. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front Physiol. 2014;5:84.
Chen GP, Huang Y, Yang X, Feng JF. A nomogram to predict prognostic value of red cell distribution width in patients with esophageal cancer. Mediators Inflamm. 2015;2015:854670.
Wei TT, Wang LL, Yin JR, Liu YT, Qin BD, Li JY, et al. Relationship between red blood cell distribution width, bilirubin, and clinical characteristics of patients with gastric cancer. Int J Lab Hematol. 2017;39:497–501.
Ichinose J, Murakawa T, Kawashima M, Nagayama K, Nitadori JI, Anraku M, et al. Prognostic significance of red cell distribution width in elderly patients undergoing resection for non-small cell lung cancer. J Thorac Dis. 2016;8:3658–66.
Życzkowski M, Rajwa P, Gabrys E, Jakubowska K, Jantos E, Paradysz A. The relationship between red cell distribution width and cancer-specific survival in patients with renal cell carcinoma treated with partial and radical nephrectomy. Clin Genitourin Cancer. 2018;16:e677–83.
Duchnowski P, Szymański P, Orłowska-Baranowska E, Kuśmierczyk M, Hryniewiecki T. Raised red cell distribution width as a prognostic marker in aortic valve replacement surgery. Kardiol Pol. 2016;74:547–52.
Ertaş G, Aydin C, Sönmez O, Erdoğan E, Turfan M, Tasal A, et al. Red cell distribution width predicts new-onset atrial fibrillation after coronary artery bypass grafting. Scand Cardiovasc J. 2013;47:132–5.
Zehir S, Sipahioğlu S, Ozdemir G, Sahin E, Yar U, Akgül T. Red cell distribution width and mortality in patients with hip fracture treated with partial prosthesis. Acta Orthop Traumatol Turc. 2014;48:141–6.
Bazick HS, Chang D, Mahadevappa K, Gibbons FK, Christopher KB. Red cell distribution width and all-cause mortality in critically ill patients. Crit Care Med. 2011;39:1913–21.
Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133:628–32.
Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158:659–66.
Seth HS, Mishra P, Khandekar JV, Raut C, Mohapatra CKR, Ammannaya GKK, et al. Relationship between high red cell distribution width and systemic inflammatory response syndrome after extracorporeal circulation. Braz J Cardiovasc Surg. 2017;32:288–94.
Zurauskaite G, Meier M, Voegeli A, Koch D, Haubitz S, Kutz A, et al. Biological pathways underlying the association of red cell distribution width and adverse clinical outcome: results of a prospective cohort study. PLoS ONE. 2018;13:e0191280.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We have no conflicts of interest to declare.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sato, R., Oikawa, M., Kakita, T. et al. Prognostic significance of the mean corpuscular volume (MCV) and red cell distribution width (RDW) in obstructive colorectal cancer patients with a stent inserted as a bridge to curative surgery. Surg Today 52, 1699–1710 (2022). https://doi.org/10.1007/s00595-022-02504-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-022-02504-9